"Global Diabetic Retinopathy Market 2015-2019 " is now available at Fast Market Research

Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease. Laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involving leakage of fluid from the minute, delicate, and previously injured blood vessels located at the back of the eye, which then collects in the macula. This results in inflammation of tissue and blurry vision.

Full Report Details at
- http://www.fastmr.com/prod/1003066_global_diabetic_retinopathy.aspx?afid=301

Technavio's analysts forecast the global diabetic retinopathy market to grow at a CAGR of 6.89% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global diabetic retinopathy market for the period 2015-2019. To calculate the market size, the report considers revenue from the sales of prescribed as well as off-label drugs available in the market.

The report also presents the vendor landscape and a corresponding detailed analysis of the four major vendors in the market. In addition, it discusses the major drivers that influence the growth and the challenges faced by the vendors and the market at large, as well as the key trends that contribute to the growth the market.

Technavio's report, Global Diabetic Retinopathy Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the global diabetic retinopathy market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

* Americas
* APAC
* EMEA

Key Vendors

* Bayer
* F. Hoffmann-La Roche
* Novartis
* Regeneron Pharmaceuticals

Other Prominent Vendors

* Actavis
* Alimera Sciences
* Ampio Pharmaceuticals
* Antisense Therapeutics
* BCN Peptides
* Boehringer Ingelheim
* Glycadia
* iCo Therapeutics
* Isis Pharmaceuticals
* Kowa Group
* Lpath
* Numoda Capital
* Ohr Pharmaceutical
* OPKO Health
* Parexel International
* Promedior
* pSivida
* Quark Pharmaceuticals
* R-Tech Ueno
* Sirnaomics
* ThromboGenics

Market Driver

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Diabetic Retinopathy Global Clinical Trials Review, H1, 2014
- Proliferative Diabetic Retinopathy (PDR) Global Clinical Trials Review, H1, 2014
- Diabetic Retinopathy - Pipeline Review, H2 2014
- Global Ophthalmic Lasers Market 2014-2018
- Wound Care Market - Global Forecast to 2019